Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
OncoC4, Inc.
Bayer
Memorial Sloan Kettering Cancer Center
Seagen Inc.
Arcus Biosciences, Inc.
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Rutgers, The State University of New Jersey
Rondo Therapeutics
The Methodist Hospital Research Institute
BeOne Medicines
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Clasp Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
Institut Bergonié
Daiichi Sankyo
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin
OncoNano Medicine, Inc.
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Pittsburgh
RenJi Hospital
University Health Network, Toronto
Cancer Research UK
NeoTX Therapeutics Ltd.
Medtronic - MITG
BicycleTx Limited
BicycleTx Limited
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
University of Arizona
Shanghai Escugen Biotechnology Co., Ltd
Sahlgrenska University Hospital
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Merck Sharp & Dohme LLC